ACTIVE

ALSINOVA BELGIUM

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result586,1 k €+119,4 %over 1 year
Revenue11,9 M €+21,7 %over 1 year
Equity1,2 M €+90,0 %over 1 year
Workforce48,9 ETP-1,2 %over 1 year

Identity

Source · BCE/KBO

ALSINOVA BELGIUM is a Public limited company incorporated in 2009. Its main activity is: Computer programming activities. Its registered office is in Waterloo. It employs on average 48,9 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0821.010.572
Incorporation
30/11/2009
Legal form
Public limited company
Registered office
Drève Richelle 161 box 18
1410 Waterloo · WallonieSee on map
Contributed capital
315 000,00 €
Latest accounts
31/12/2024
Average workforce
48,9 ETP
Joint committees (2)
  • 200
  • 218
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 15 filings

Trend over 15 financial years

20242023202220212020
Income statement
Revenue11,9 M €9,8 M €9,6 M €9,4 M €9,6 M €
EBITDA896,7 k €-89 k €177,3 k €91,3 k €-655,7 k €
Operating result861,1 k €-129,6 k €142 k €71,6 k €-775,2 k €
Net result586,1 k €267,2 k €70,7 k €-11,5 k €-859,5 k €
Balance sheet
Equity1,2 M €651,2 k €384 k €313,2 k €324,8 k €
Total assets4,7 M €4,7 M €5,9 M €4,9 M €4,6 M €
Cash1,2 M €1,2 M €1,1 M €711,6 k €1,5 M €
Debts3,4 M €3,9 M €5,4 M €4,3 M €4,3 M €
Other
Workforce48,9 ETP49,5 ETP52,5 ETP46,8 ETP55,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

3 active · 20 ended

Active mandates

LINEST

Managing director · since 23 janvier 2024 · until 24 mai 2029 · 0656.758.888

Represented by Marc Stukkens Marc

Active
ERIC COHEN

Director · since 28 mai 2020 · until 22 mai 2025

Active
REBECCA COHEN

Director · since 28 mai 2020 · until 22 mai 2025

Active

Ended mandates

ERIC COHEN

Director · since 28 mai 2020 · until 28 mai 2025

Ended
REBECCA COHEN

Director · since 28 mai 2020 · until 28 mai 2025

Ended
Marc Stukkens

Director · since 31 octobre 2019 · until 31 décembre 2024

Ended
Marc STUKKENS

Director · since 31 octobre 2019 · until 23 mai 2024

Ended

Other companies at this address

Drève Richelle 161 1410 Waterloo
CompanyCBE no.
ACTA QUALITA● Bankrupt
0764.988.817
Aderys● Active
0824.466.445
ADERYS BW● Active
0507.744.322
ADERYS IMMO● Active
0719.905.492
ADVANCED MEDICAL DIAGNOSTICS● Bankrupt
0861.161.446
ADVENCI● Active
0729.985.079
AgenTus Therapeutics● Bankrupt
0702.962.265
AHP PROPERTIES● Active
0841.224.877
A++ INFORMATIQUE● Active
0430.167.779
ALCANTARA● Active
1038.720.738
ALGA MARIS● Active
0759.673.217
ALGUE ROUGE● Active
0739.650.338
ANSE 505● Active
0685.928.768
APRIL BELGIUM● Active
0627.678.387
ARNAGA● Active
0820.710.169
ATHENA FILMS● Active
0543.379.251
ATOME HVAC● Active
1023.502.230
AUDIT-Manager● Active
0769.768.145
AULY● Active
1019.289.361
AURORE LAFOSSE PLASTIC SURGERY● Active
0698.705.351

Full financial information

Source · NBB
202420232022202120202019
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date17/06/202526/06/202404/07/202323/06/202212/10/202116/12/2020
General meeting22/05/202523/05/202428/06/202327/05/202227/05/202129/07/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202422/05/202517/06/2025FrenchPDF
Full model31/12/202323/05/202426/06/2024FrenchPDF
Full model31/12/202228/06/202304/07/2023FrenchPDF
Full model31/12/202127/05/202223/06/2022FrenchPDF
Full model31/12/202027/05/202112/10/2021FrenchPDF
Full model31/12/201929/07/202016/12/2020FrenchPDF
Full model31/12/201823/05/201904/07/2019FrenchPDF
Full model31/12/201724/05/201805/09/2018FrenchPDF
Full model31/12/201626/05/201730/08/2017FrenchPDF
Full model31/12/201527/05/201606/09/2016FrenchPDF
Full model31/12/201414/05/201504/09/2015FrenchPDF
Full model31/12/201322/05/201430/09/2014FrenchPDF
Full model31/12/201223/05/201306/08/2013FrenchPDF
Full model31/12/201124/05/201206/07/2012FrenchPDF
Full model31/12/201026/05/201127/07/2011FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

3 active · 20 ended

Active mandates

LINEST

Managing director · since 23 janvier 2024 · until 24 mai 2029 · 0656.758.888

Represented by Marc Stukkens Marc

Active
ERIC COHEN

Director · since 28 mai 2020 · until 22 mai 2025

Active
REBECCA COHEN

Director · since 28 mai 2020 · until 22 mai 2025

Active

Ended mandates

ERIC COHEN

Director · since 28 mai 2020 · until 28 mai 2025

Ended
REBECCA COHEN

Director · since 28 mai 2020 · until 28 mai 2025

Ended
Marc Stukkens

Director · since 31 octobre 2019 · until 31 décembre 2024

Ended
Marc STUKKENS

Director · since 31 octobre 2019 · until 23 mai 2024

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/09/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates07/07/2025
    DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/04/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates04/06/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates11/10/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/01/2022
    DENOMINATION - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Capital / shares02/02/2021
    CAPITAL, ACTIONS
    PDF
  • Mandates05/05/2020
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024586,1 k €↑
  2. 2023
    Annual accounts 2023267,2 k €↑
  3. 2022
    Annual accounts 202270,7 k €↑
  4. 2021
    Annual accounts 2021-11,5 k €↑
  5. 2021
    Name changeKeyrus Life Science
  6. 2020
    Annual accounts 2020-859,5 k €↓
  7. 2019
    Annual accounts 2019-703,7 k €↓
  8. 2018
    Annual accounts 2018-402,7 k €↓
  9. 2017
    Annual accounts 201760 k €↑
  10. 2016
    Annual accounts 2016-35,5 k €↓
  11. 2015
    Annual accounts 201511,4 k €↓
  12. 2014
    Annual accounts 201427,9 k €↑
  13. 2013
    Annual accounts 20132,8 k €↓
  14. 2012
    Annual accounts 2012115,8 k €↑
  15. 2011
    Annual accounts 2011-109,6 k €↓
  16. 2010
    Annual accounts 20103 k €
  17. 2010
    Name changeKeyrus Biopharma
  18. 30/11/2009
    IncorporationPublic limited company